General Resources
These resources relate to the issues that MeTA is concerned with, both internally and externally produced. Clicking on one of the links may take you away from the MeTA website, to the source of that information.
How the counterfeit bill can negatively affect access to medicines in Uganda
Uganda largely depends on generic medication to treat the sick, but a new Counterfeit Bill may put a stop to the cheaper drugs.
Benchmarking antiretroviral prices in countries of the former Soviet Union
A study comparing the price of antiretroviral medicines in the former Soviet Union with prices in elsewhere in Europe and globally.
ASEAN ministers sign drug accord
ASEAN Economic Ministers sign deal on safety, quality, efficacy and lower prices of drugs sold in the region - Philippine Daily Inquirer
Edinburgh to be the first British university to help make medicines cheaper in developing world
Edinburgh will be the first British university to license research to pharmaceutical companies only on condition that poorer communities get life-saving drugs at cost price.
Malaria drugs cheaper in £150m deal to save lives
Up to 300,000 lives a year could be saved by a groundbreaking international deal that will slash the cost of medicines to fight malaria - The Guardian, UK
Procurement of contraceptives in Latin America and the Caribbean
This report summarises experiences and lessons learned while facing new procurement challenges in 14 countries in the Latin American and Caribbean region.
GlaxoSmithKline announces price cuts and patent sharing
GlaxoSmithKline will share more than 800 drug patents with others hunting new cures for neglected tropical diseases and reduce the price of more than 110 medicines - Reuters.
The Drum Beat - Issue 486 - Medicines Transparency: Access, Quality, and Accountability
This issue of The Drum Beat e-magazine, produced by the Communications Initiative Network, focuses on Medicines Transparency and highlights MeTA
Drug giant GlaxoSmithKline pledges cheap medicine for world's poor
The world's second biggest pharmaceutical company is to radically shift its attitude to providing cheap drugs to millions of people in the developing world.
Measuring medicine prices, availability, affordability and price components 2ND EDITION
The second edition of the manual for the Health Action International/World Health Organization pricing survey tool.